Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2017 Dec 12;73(1):4-10.
doi: 10.1093/gerona/glx096.

Change in the Rate of Biological Aging in Response to Caloric Restriction: CALERIE Biobank Analysis

Daniel W Belsky  1   2   3   4 , Kim M Huffman  1   2   5 , Carl F Pieper  1   2   6 , Idan Shalev  7 , William E Kraus  1   2   5
Affiliations
Randomized Controlled Trial

Change in the Rate of Biological Aging in Response to Caloric Restriction: CALERIE Biobank Analysis

Daniel W Belsky et al. J Gerontol A Biol Sci Med Sci. .

Abstract

Biological aging measures have been proposed as proxies for extension of healthy life span in trials of geroprotective therapies that aim to slow aging. Several methods to measure biological aging show promise but it is not known if these methods are sensitive to changes caused by geroprotective therapy. We conducted analysis of two proposed methods to quantify biological aging using data from a recently concluded trial of an established geroprotector, caloric restriction. We obtained data from the National Institute on Aging CALERIE randomized trial through its public-access biobank (https://calerie.duke.edu/). The CALERIE trial randomized N = 220 nonobese adults to 25% caloric restriction (n = 145; 11.7% caloric restriction was achieved, on average) or to maintain current diet (n = 75) for 2 years. We analyzed biomarker data collected at baseline, 12-, and 24-month follow-up assessments. We applied published biomarker algorithms to these data to calculate two biological age measures, Klemera-Doubal Method Biological Age and homeostatic dysregulation. Intent-to-treat analysis using mixed-effects growth models of within-person change over time tested if caloric restriction slowed increase in measures of biological aging across follow-up. Analyses of both measures indicated caloric restriction slowed biological aging. Weight loss did not account for the observed effects. Results suggest future directions for testing of geroprotective therapies in humans.

Keywords: Biological age; Caloric restriction; Geroprotector; Geroscience.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
CALERIE participants’ KDM Biological Ages were highly correlated with their chronological ages at the time of baseline assessment but tended to be slightly younger. The plotted line shows a one-to-one correspondence between biological age and chronological age. The larger number of plotted points below the line as compared to above the line indicates that CALERIE participants’ KDM Biological Ages tended to be slightly younger than their chronological ages.
Figure 2.
Figure 2.
Change in KDM Biological Age from Baseline to 12- and 24-month follow-ups in the ad libitum (black dots) and caloric-restriction (blue dots) arms of the CALERIE trial. Panel A shows mean values with 95% confidence intervals calculated for each follow-up. Panel B shows slopes estimated from the growth model with the shaded areas indicating 95% confidence intervals.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Harper S. Economic and social implications of aging societies. Science. 2014;346:587–591. doi:10.1126/science.1254405. - PubMed
    1. Burch JB, Augustine AD, Frieden LA et al. . Advances in geroscience: impact on healthspan and chronic disease. J Gerontol A Biol Sci Med Sci. 2014;69(suppl 1):S1–S3. doi:10.1093/gerona/glu041. - PMC - PubMed
    1. Kennedy BK, Berger SL, Brunet A et al. . Geroscience: linking aging to chronic disease. Cell. 2014;159:709–713. doi:10.1016/j.cell.2014.10.039. - PMC - PubMed
    1. Fontana L, Kennedy BK, Longo VD, Seals D, Melov S. Medical research: treat ageing. Nature. 2014;511:405–407. doi:10.1038/511405a. - PubMed
    1. Moskalev A, Chernyagina E, Tsvetkov V et al. . Developing criteria for evaluation of geroprotectors as a key stage toward translation to the clinic. Aging Cell. 2016;15:407–415. doi:10.1111/acel.12463. - PMC - PubMed

Publication types